Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer

Endoxifen, a New Cornerstone of Breast Cancer Therapy: Demonstration of Safety, Tolerability, and Systemic Bioavailability in Healthy Human Subjects

(2010) A Ahmad et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

(2010) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

CYP2D6 Polymorphisms and Tamoxifen Metabolism: Clinical Relevance

(2010) Michaela J. Higgins et al.   Current Oncology Reports

Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort

(2009) N. Lynn Henry et al.   BREAST CANCER RESEARCH AND TREATMENT

In VitroKinetic Properties of the Thr201Met Variant of Human Aromatase Gene CYP19A1: Functional Responses to Substrate and Product Inhibition and Enzyme Inhibitors

(2009) E. J. Payne et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

X-ray structure of human aromatase reveals an androgen-specific active site

(2009) Debashis Ghosh et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY